CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-12 | LEVINE ARNOLD J Director | Grant or award · Stock Option (right to buy) | +5,781 | 5,781 | ||
| 2021-05-12 | Jalota Deepika SVP, Regulatory Affairs and QA | Grant or award · Employee Stock Option (right to buy) | +22,674 | 22,674 | ||
| 2021-05-12 | Alland Leila Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +36,279 | 36,279 | ||
| 2021-05-12 | Kung Winston COO, CFO | Grant or award · Employee Stock Option (right to buy) | +50,337 | 50,337 | ||
| 2021-05-12 | Mack David Henry President and CEO | Grant or award · Employee Stock Option (right to buy) | +134,584 | 134,584 | ||
| 2021-05-10 | Schroeder Thilo Director | Sale | −1,787 | $35.67 | $64K | 2,104,414 |
| 2021-05-10 | INTERWEST PARTNERS X LP 10% owner | Other disposition | −500,000 | 4,969,911 | ||
| 2021-05-10 | INTERWEST PARTNERS X LP 10% owner | Other acquisition | +5,000 | 5,000 | ||
| 2021-05-10 | INTERWEST PARTNERS X LP 10% owner | Other disposition | −5,000 | 0 | ||
| 2021-05-10 | INTERWEST PARTNERS X LP 10% owner | Other acquisition | +186 | 559 | ||
| 2021-05-10 | INTERWEST PARTNERS X LP 10% owner | Other acquisition | +125 | 375 | ||
| 2021-05-10 | INTERWEST PARTNERS X LP 10% owner | Other acquisition | +1,135 | 3,404 | ||
| 2021-05-07 | Alland Leila Chief Medical Officer | Exercise or conversion | +4,000 | $3.90 | $16K | 4,000 |
| 2021-05-07 | Alland Leila Chief Medical Officer | Sale | −3,842 | $34.80 | $134K | 158 |
| 2021-05-07 | Alland Leila Chief Medical Officer | Sale | −158 | $35.49 | $6K | 0 |
| 2021-05-07 | Alland Leila Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −4,000 | 369,850 | ||
| 2021-05-05 | Schroeder Thilo Director | Sale | −600 | $35.64 | $21K | 2,106,201 |
| 2021-05-03 | Kung Winston COO, CFO | Exercise or conversion | +4,500 | $3.22 | $14K | 6,100 |
| 2021-05-03 | Kung Winston COO, CFO | Sale | −4,500 | $33.75 | $152K | 1,600 |
| 2021-05-03 | Kung Winston COO, CFO | Exercise or conversion · Stock Option (right to buy) | −4,500 | 232,534 |
Page 16 of 23 · 457 trades